Register entry
AltaThera Pharmaceuticals LLC
- Registered sites
- 1
- Drug products
- 1
- Live patents
- 7
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Finished drug manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| AltaThera Pharmaceuticals LLC | Chicago, ILUnited States | Finished drug manufacture | 3013989010 |
Exclusivity
Patents
7Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| SOTALOL HYDROCHLORIDE | SOTALOL HYDROCHLORIDE | Aug 2028 |
| SOTALOL HYDROCHLORIDE | SOTALOL HYDROCHLORIDE | Aug 2038 |
| SOTALOL HYDROCHLORIDE | SOTALOL HYDROCHLORIDE | Apr 2039 |
| SOTALOL HYDROCHLORIDE | SOTALOL HYDROCHLORIDE | Aug 2039 |
Catalogue
Marketed products
1Showing 1 of 1.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Sotalol hydrochloride | Sotalol hydrochloride | INJECTION | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.